FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Conditions:   Pancreas Cancer;   Adenocarcinoma of the Pancreas Interventions:   Drug: Digoxin;   Drug: 5Fluorouracil;   Drug: Calcium Leucovorin;   Drug: Irinotecan;   Drug: Oxaliplatin Sponsors:   Jean Grem, MD;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials